March 8, 2021
Q&A: Behind the scenes of Together: Canada's Hospital Pharmacy Conference
Are you curious about what it takes to plan a virtual conference for over 750 attendees? To find out, we sat down to chat with Christina Adams, CSHP’s Chief Pharmacy Officer. Christina has long been an active member of CSHP – she’s held multiple leadership roles at the national level – but …
March 5, 2021
Attention: Canadian pharmacists working in primary care settings
Dr. Nicole Domanski is a clinical pharmacist at the University of British Columbia Pharmacists Clinic. You're invited to participate in her study to characterize the impact of pharmacists’ consultation notes on prescribers' healthcare decisions. If you work in a team-based primary care role, p…
March 5, 2021
Preventing Errors with COVID-19 Vaccines: Learning from Vaccine Incidents
Download a .pdf copy here.
Audio summaries of the latest ISMP Canada Safety Bulletins (approximately 1 minute each) can be accessed here: https://www.ismp-canada.org/ISMPCSafetyBulletins.htm
March 5, 2021
Health Product InfoWatch: February 2021 - InfoVigilance sur les produits de santé: février 2021
Health Product InfoWatch, published monthly by Health Canada, includes a recap of health product advisories and summary safety reviews published in the previous month, as well as a growing selection of new health product safety information. The goal of the Health Product InfoWatch is to…
March 4, 2021
Notice for 2021 Sabbatical Grant competition
APPLY NOW for an Education Sabbatical Grant The CSHP Foundation is pleased to offer dedicated funding to a maximum of $5,000 to support an Education Sabbatical Grant CSHP Foundation Sabbatical Grant eligibility criteria Applicant is a current CSHP member. Applicant has been a CSHP m…
February 23, 2021
Metoclopramide 2mL Vial Shortage
CSHP has been informed that there will a disruption in the supply of metoclopramide 5 mg/mL, 2 mL vial size, for at least two weeks in March. This in turn could lead to critically low inventory at some facilities. It is recommended that mitigation strategies be used to conserve the remaining supply…
February 22, 2021
Health Canada: Special Access Program Regulations Changes
Health Canada’s Special Access Program (SAP), and the Emergency Drug Release (EDR) Program are used when a serious or life-threatening condition may require new drugs when conventional therapies have failed, are unsuitable, or unavailable. The regulations surrounding these programs are currently be…
February 22, 2021
The weird and wonderful: Inherited Retinal Degenerations
CSHP is delighted to share with you our second installment in a new series of Weird and Wonderful conditions that you may encounter in your practice. Click here to read our first Weird and Wonderful piece in December. Inherited Retinal Degenerations (IRDs), also kno…
February 19, 2021
Health Canada: Cost-Benefit Analysis Survey for Transitioning Regulations of Interim Orders into Permanent Regulations
In 2020, Health Canada developed interim orders to help prevent and alleviate drug and medical device shortages. The interim orders & measures are with respect to: (1) Drugs, Medical Devices, and Foods for a Special Dietary Purpose in Relation to COVID-19 can be found here (2)…
February 19, 2021
Adrenal insufficiencies & COVID-19
The adrenal cortex produces hormones (glucocorticoids, mineralocorticoids, and androgens), which are necessary for normal body functioning. When the adrenal cortex is damaged, enough glucocorticoids and mineralocorticoids are not produced leading to deficiencies of these hormones. Adrena…
Categories
- A.P.E.S.
- Advocacy
- Choosing Wisely Canada
- CJHP
- Health Canada
- PPC 2020
- CSHP News
- Corporate
- CPRB | RB News
- CSHP Foundation
- Distinguished Service Award Corner
- Membership
- Products and Publications
- PSNs
- Year in Review Reports
- Webinar
- ISMP Canada Safety Bulletin
- Volunteer Opportunities
- Surveys and Consultations
- Non-CSHP News